Drug profile · INN
inhibitors
inhibitors is an FDA-listed pharmaceutical active ingredient.
Drug details — inhibitors
- Class
- —
- Route
- —
- Patents
- 20
- Programs
- 37
- Data quality
- 0.70
Quick answer
inhibitors is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related patents
-
US 20260083736
GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDER IN PATIENTS WITH HIGH IMPULSIVITY
granted -
US 20260055120
Bicyclic pyrimidinones as inhibitors of NOX4
granted -
US 20260008777
INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
granted -
US 20260001878
SUBSTITUTED PYRROLOPYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF TLR9
granted -
US 2025304535
KAT6 Inhibitors
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12428379
Acylsulfonamide KAT6A inhibitors
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12421273
Ectonucleotidase inhibitors and methods of use thereof
granted -
US 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
US 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted -
US 12421249
Inhibitors of APOL1 and methods of using same
granted -
US 12414953
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 12414981
JNK inhibitors for use in treating and preventing neurodegenerative disorders
granted -
US 12409225
Ras inhibitors
granted -
US 12403196
Ras inhibitors
granted -
US 12403141
Deuterated MK2 pathway inhibitors and methods of using the same
granted -
US 12404243
Inhibitors of the Wnt/beta-catenin pathway
granted
Frequently asked questions
What is inhibitors?
inhibitors is an FDA-listed pharmaceutical active ingredient.